WuXi AppTec Science Forum

WuXi AppTec Science Forum

By WuXi AppTec

Where Science Meets Innovation

Date and time

Location

Pullman Basel Europe

43 Clarastrasse 4058 Basel Switzerland

Agenda

8:00 AM - 9:00 AM

Coffee Time | Poster Session | Check-in

9:00 AM - 9:10 AM

Opening Remarks

Lecture Session | “From Target to IND”

Innovators Talks

Michal Shoshan, CEO, metaLead Therapeutics

Luc Otten, CEO, TheraPPI

David Nippa, Automation Digitalization Scientist,Roche,

9:10 AM - 9:35 AM

Beyond Borders: Accelerating Peptide Oligonucleotide Conjugate (POC) Programs

Dr. Yvonne Angell, Executive Director,WuXi TIDES

Dr. Yvonne M. Angell has over 20 years of experience in therapeutic peptide research, with leadership roles at Eli Lilly, Pfizer, Affymax, Ipsen, ChemPartner, GenEdit, and currently serves as Executi...

9:35 AM - 10:00 AM

Accelerating the Discovery of Nucleic Acid Therapeutics

Dr. Lijuan Pang, Director, WuXi Biology

Lijuan Pang studied Pharmacy and Chemical Biology at Peking University in China, and then she obtained her PhD in Pharmaceutical Sciences from the University of Basel in Switzerland, followed by post...

10:00 AM - 10:25 AM

Animal Models To Support New Modality Drug Discovery

Dr. Fugang Li, Director, WuXi Biology

Dr. Fugang (Frank) Li is a distinguished leader in animal models, boasting over 20 years of experience in biopharmaceutical research and animal model development in the United States. Prior to joinin...

10:25 AM - 10:50 AM

The Neuro-Revolution: Mapping the Future of CNS Therapeutics

Dr. Juan Tan, Director, WuXi Biology

Dr. Juan Tan is an expert in genetics and pharmacology, specializing in preclinical drug development. She earned her Ph.D. in Genetics from Shanghai Jiao Tong University in 2015. After graduation, sh...

10:50 AM - 11:15 AM

Navigating Complexities in Oligonucleotides: DMPK Strategies and CNS-Targeting

Dr. Jing Jin, Senior Director, WuXi Testing

Dr. Jing Jin currently serves as the Senior Director, heading the DMPK Study Director team at WuXi AppTec. Before joining WuXi AppTec in 2016, he worked as an Investigator of Clinical Pharmacology at...

11:15 AM - 12:00 PM

Panel Discussion | “From Investment to Innovation”

Aksana Labokha, General Partner, RegenEra Ventures

Lev Osherovich , Co-Founder, Nonsense Therapeutics

Xi Zhang, CEO, SuperLab Suisse

Kelvin Stott, CEO, Amporin Pharmaceuticals

Panel Discussion Chairperson

Valentina Francia

Valentina Francia, Manager, Ecosystems and Investment Promotion, BaselArea

12:00 PM - 1:00 PM

Lunch Break | Poster Session | Social Time | 1-on-1 meetings

Lecture Session | “From IND to NDA”

1:00 PM - 1:25 PM

Understanding and Mitigating Class-Specific Toxicities of Oligonucleotides

Dr. Deping Cheng, Senior Director, WuXi Testing

Dr. Deping Cheng has extensive experience as a Program Manager in the life sciences, pharmaceutical, and CRO industries, with a strong track record in managing complex development programs. Skilled i...

1:25 PM - 1:50 PM

The Challenges and Solutions of Clinical Bioanalysis of Therapeutic Biologics

Dr. Jianbo Diao, Director, WuXi Testing

Dr. Jianbo Diao, Director of Bioanalytical Services (BAS) is in charge of the Business Translational Team. Dr. Diao focuses on PKPD and immunogenicity analysis of biological therapeutic products such...

1:50 PM - 2:15 PM

Application of Flow Chemistry to Accelerate Drug Discovery

Dr. Tao Guo, Senior Vice President, WuXi Chemistry

Dr. Tao Guo, Head of Research Chemistry Service Business Development and Integrated Project Management, has over 20 years of experience in drug discovery, recipient of over 40 US issued patents and...

2:15 PM - 2:40 PM

Drug Delivery And Formulation Strategy to Move New Drug Candidate

Liang Mao, Executive Director, WuXi STA

Dr. Liang Mao joined WuXi STA for more than 8 years and now manages the developability and formulation research team. Prior to WuXi STA, Liang worked at Novartis for around 6 years in pre-formulation...

2:40 PM - 3:05 PM

Key Aspects of Process Development and Quality Control in Clinical API Supply

Dr. Yu Lu, Executive Director, WuXi STA

Dr. Yu Lu received a PhD in Organic Chemistry from the University of Texas at Austin in 2012. He then moved to Indinana to work at Corteva Agriscience and Eli Lilly for a total of 10 years, where he ...

Good to know

Highlights

  • 7 hours, 5 minutes
  • In person

About this event

Science & Tech • Biotech

This forum brings together respected experts and innovation leaders to share the latest advances and empower your journey in drug R&D. From target validation to preclinical candidate selection, we’ll cover a range of modalities including small molecules, peptides, oligonucleotides, and antibody-drug conjugates (ADCs) - through insightful talks, dynamic panels, poster sessions, and a networking lunch.

During our forum, a poster session will also be held. If you wish to present a poster, please submit it via the link in the order form. We will inform you if your poster is accepted. Awards will be given to the top posters.

We look forward to welcoming you for a day of meaningful exchanges and fresh perspectives.

Please note: All registrations will be reviewed before attendance is confirmed.

Organised by

WuXi AppTec

Followers

--

Events

--

Hosting

--

Free
Sep 11 · 08:00 GMT+2